DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Mountzios G, Terpos E, Syrigos K et al.
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Transl Res 2010;
155: 247-255
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.